FH and hemolytic-uremic syndrome: Since we observed that the N-glycans of FH in SP-HUS patients show glycosylation alterations beyond desialylation (Figures 2, 3, Supplementary Figure 3), we evaluated the functionality of FH immunoprecipitated from SP-HUS patient samples and compared it to the wild type.